Final results of BIRCOV trial (ARB, ACEI, DRi in COVID-19)

Final results of BIRCOV trial (ARB, ACEI, DRi in COVID-19)

Background. The question of the possible effect of the inhibitors of the renin-angiotensin system (iRAS) on hypertensive subjects who fell ill with COVID-19 has been discussed in the literature. SARS-CoV-2 is well-known to use an angiotensin-converting enzyme 2 receptors facilitating virus entry int...

Full description

Bibliographic Details
Main Authors: D.D. Ivanov, M.D. Ivanova, T. Crestanello
Format: Article
Language:English
Published: Publishing House Zaslavsky 2021-09-01
Series:Počki
Subjects:
renin-angiotensin system inhibitors, angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, direct renin inhibitor, covid-19, bircov trial
Online Access:http://kidneys.zaslavsky.com.ua/article/view/239591

Similar Items

Similar Items